Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Cash (2016 - 2025)

IGC Pharma (IGC) has disclosed Change in Cash for 16 consecutive years, with $651000.0 as the latest value for Q3 2025.

  • Quarterly Change in Cash rose 334.17% to $651000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$441000.0 through Sep 2025, up 70.2% year-over-year, with the annual reading at -$793000.0 for FY2025, 60.31% up from the prior year.
  • Change in Cash for Q3 2025 was $651000.0 at IGC Pharma, up from $49000.0 in the prior quarter.
  • The five-year high for Change in Cash was $13.6 million in Q1 2021, with the low at -$2.5 million in Q4 2021.
  • Average Change in Cash over 5 years is $7210.5, with a median of -$1.1 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 573.01% in 2021, while the deepest fall reached 1243.17% in 2021.
  • Over 5 years, Change in Cash stood at -$2.5 million in 2021, then soared by 31.73% to -$1.7 million in 2022, then increased by 1.79% to -$1.6 million in 2023, then skyrocketed by 34.71% to -$1.1 million in 2024, then surged by 160.5% to $651000.0 in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $651000.0, $49000.0, and -$65000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.